<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30100994</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Electronic">1949-2553</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>9</Volume>                    <Issue>54</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Jul</Month>                        <Day>13</Day>                    </PubDate>                </JournalIssue>                <Title>Oncotarget</Title>                <ISOAbbreviation>Oncotarget</ISOAbbreviation>            </Journal>            <ArticleTitle>Risk factors for loco-regional recurrence in breast cancer patients: a retrospective study.</ArticleTitle>            <Pagination>                <MedlinePgn>30355-30362</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.25735</ELocationID>            <Abstract>                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Although fairly uncommon, loco-regional recurrence in breast cancer (BC) has major consequences for the patient. Several predictors for locoregional have been previously reported from large randomized clinical trials mainly from Europe &amp; North America; data from other geographical areas are somewhat scarce. Here we performed a retrospective review of medical records in a single academic center in Chile, searching for predictors of breast tumor recurrence.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Median patient follow up was 61 months, 5 year overall survival (OS) rate was 94.2% (95% CI 93-95.3). We found that 108 out of 2,754 (5.3%) patients had loco-regional recurrence. The 2-year loco-regional control was 98% (95% CI 97.3-98.7) and 5-year was 94% (95% CI 92.6-95.4). Univariate analysis showed a correlation between recurrence and being &lt;50 year-old, positive surgical margins, advanced stage, subtype, and presence of LVI and omission of adjuvant radiotherapy. Only the absence of adjuvant RT was predictor of locoregional recurrence in multivariable (<i>p</i><b>&lt;</b> 0.001).</AbstractText>                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Our study population presents high local control of BC. Age, surgical margins, stage, molecular subtype and absence of adjuvant radiotherapy were associated with loco-regional recurrence. Prospective trials and long-term follow up are required in order to confirm these results.</AbstractText>                <AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">We analyzed medical records from 2,201 BC patients at the Pontificia Universidad Católica de Chile from 1997 to 2016. Collected data included: age at diagnosis, tumor size, axillary involvement, molecular subtype, margin status, histological grade, lympho-vascular invasion (LVI) and ipsilateral recurrence.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y" EqualContrib="Y">                    <LastName>Merino</LastName>                    <ForeName>Tomás</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y" EqualContrib="Y">                    <LastName>Ip</LastName>                    <ForeName>Teresa</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Domínguez</LastName>                    <ForeName>Francisco</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Acevedo</LastName>                    <ForeName>Francisco</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Medina</LastName>                    <ForeName>Lidia</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Villaroel</LastName>                    <ForeName>Alejandra</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Camus</LastName>                    <ForeName>Mauricio</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vinés</LastName>                    <ForeName>Eugenio</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sánchez</LastName>                    <ForeName>César</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>13</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Oncotarget</MedlineTA>            <NlmUniqueID>101532965</NlmUniqueID>            <ISSNLinking>1949-2553</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Aug;128(3):899-906</RefSource>                <PMID Version="1">21475999</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2017 Oct 1;35(28):3222-3229</RefSource>                <PMID Version="1">28759347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):998-1004</RefSource>                <PMID Version="1">19560883</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2005 Dec 17;366(9503):2087-106</RefSource>                <PMID Version="1">16360786</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1095-101</RefSource>                <PMID Version="1">20638197</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Nov 12;378(9804):1707-16</RefSource>                <PMID Version="1">22019144</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):23-33</RefSource>                <PMID Version="1">8083119</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1991 Nov;19(5):403-10</RefSource>                <PMID Version="1">1757079</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2006 May 1;24(13):2028-37</RefSource>                <PMID Version="1">16648502</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2002 Oct 17;347(16):1233-41</RefSource>                <PMID Version="1">12393820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):719-25</RefSource>                <PMID Version="1">2777661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2010 Jun;17(6):1471-4</RefSource>                <PMID Version="1">20180029</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):255-61</RefSource>                <PMID Version="1">2841261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2015;16(4):1455-61</RefSource>                <PMID Version="1">25743815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2002 Sep-Oct;52(5):277-300</RefSource>                <PMID Version="1">12363326</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Apr 1;28(10):1684-91</RefSource>                <PMID Version="1">20194857</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Jun 1;28(16):2784-95</RefSource>                <PMID Version="1">20404251</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">local recurrence</Keyword>            <Keyword MajorTopicYN="N">predictors</Keyword>            <Keyword MajorTopicYN="N">regional recurrence</Keyword>            <Keyword MajorTopicYN="N">subtype</Keyword>        </KeywordList>        <CoiStatement>CONFLICTS OF INTEREST None.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30100994</ArticleId>            <ArticleId IdType="doi">10.18632/oncotarget.25735</ArticleId>            <ArticleId IdType="pii">25735</ArticleId>            <ArticleId IdType="pmc">PMC6084401</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>